Point72 Europe’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-49,400
Closed -$13.1M 168
2025
Q1
$13.1M Buy
+49,400
New +$12.2M 0.9% 42
2022
Q3
Sell
-31,900
Closed -$6.53M 57
2022
Q2
$6.53M Sell
31,900
-1,100
-3% -$233K 1.38% 26
2022
Q1
$7.85M Buy
33,000
+10,000
+43% +$2.35M 1.34% 20
2021
Q4
$5.25M Sell
23,000
-11,300
-33% -$2.49M 2.4% 17
2021
Q3
$6.63M Buy
34,300
+5,900
+21% +$1.2M 3.35% 15
2021
Q2
$6.04M Buy
+28,400
New +$6M 4.17% 13
2019
Q2
Sell
-24,200
Closed -$3.98M 12
2019
Q1
$3.98M Buy
+24,200
New +$4.28M 3.19% 10
2017
Q4
Sell
-32,300
Closed -$4.38M 26
2017
Q3
$4.38M Buy
+32,300
New +$4.08M 2.2% 16
2017
Q1
Sell
-33,600
Closed -$3.88M 69
2016
Q4
$3.88M Buy
+33,600
New +$3.74M 1.36% 27

Other funds holding CME

Point72 Europe's CME Position: Q2 2025 in Review

Point72 Europe sold out of CME Group (CME) in Q2 2025, closing a stake of 49,400 shares — an estimated $13.1M sold.

Point72 Europe first reported a position in CME in Q4 2016 and held it in 9 quarters. The position peaked at $13.1M in Q1 2025. 1,660 funds tracked by Wall St. Rank hold CME as of Q2 2025.

  • Point72 Europe reported no remaining CME Group position as of Q2 2025 after selling out during the quarter.
  • Point72 Europe sold 49,400 CME Group shares in Q2 2025, an estimated $13.1M.
  • Point72 Europe first reported a position in CME Group in Q4 2016 and held it in 9 quarters.
  • Point72 Europe's CME Group position peaked at $13.1M in Q1 2025.
  • 1,660 funds tracked by Wall St. Rank held CME Group as of Q2 2025.

Based on Point72 Europe's 13F filing for Q2 2025, filed 14 Aug 2025.